Dow Up 1.31% Nasdaq Up 2.40%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
16.66 Up 0.22(1.34%) Oct 21, 4:00PM EDT
|After Hours : 16.66 0.00 (0.00%) Oct 21, 4:30PM EDT
Prev Close:16.44
Open:16.64
Bid:14.71 x 2000
Ask:N/A
1y Target Est:22.67
Beta:-0.42
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:16.20 - 16.79
52wk Range:8.57 - 20.29
Volume:437,900
Avg Vol (3m):529,168
Market Cap:1.26B
P/E (ttm):N/A
EPS (ttm):-0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBIX

Comparison

Symbol% ChgMkt Cap
NBIXUp 1.34%1.26B
ABTUp 2.24%63.74B
LLYUp 2.50%69.32B
PFEUp 1.25%179.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):855.46
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-14) :-0.81
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.61

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. discovers, develops, and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback